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(To the Editor: Multidetector computed tomography (MDCT) is
frequently used as the first-line technique to directly visualize
pulmonary embolism (PE) with a reported sensitivity and speci-
ficity of 83% to 100% and 89% to 97%, respectively (1). However,
for rapid and profound clinical decision making and prognostica-
tion, accurate detection of right ventricular (RV) dysfunction and
pulmonary perfusion impairment remains pivotal because such
patients are at higher risk of an adverse outcome (2).
The present study used a single-session, multicomponent car-
diovascular magnetic resonance (CMR) imaging protocol facilitat-
ing, first, the visualization of pulmonary thrombi; second, the
precise evaluation of RV volumes/function; and third, pulmonary
perfusion on a parenchymal level.
Twelve patients (5 men; mean age, 63.1  19.8 years) with
documented PE on contrast-enhanced MDCT (Somatom Sensa-
tion 64, Siemens Medical Solutions, Forchheim, Germany) and 14
healthy controls (7 men; mean age, 39.3  16.0 years) underwent
multicomponent CMR imaging. On MDCT, the presence of PE
was defined by visualization of thrombi in1 image slice in at least
2 imaging planes or if vessel truncation implied total occlusion.
Multicomponent CMR imaging (Achieva 1.5-T magnetic res-
onance [MR] system equipped with a 32-channel coil, Philips,
Best, the Netherlands) was performed as follows: 1) standard cine
imaging (repetition time/echo time [TR/TE]/flip angle, 3.4 ms/
1.7 ms/60°; spatial resolution, 1.8  1.8  8 mm3) using multiple
standard views (i.e., short-axis orientation with full ventricular
coverage and 2-, 3-, and 4-chamber orientation); 2) high-
resolution, contrast-enhanced dynamic pulmonary perfusion im-
aging in coronal slice orientation (multislice 2-dimensional, k-t
accelerated magnetic resonance sequence; TR/TE/flip angle, 2.5
ms/0.9 ms/15°; spatial resolution, 1.4  1.4  12 mm3; k-t factor,
6.0; net acceleration factor, 5.0) during a peripheral intravenous
injection of a gadolinium-diethylenetriaminepentaacetic acid bolus
(0.1 mmol/kg bodyweight; injection rate, 4.0 ml/s) (3); 3) a
3-dimensional MR angiography scan (TR/TE/flip angle, 2.9
ms/1.0 ms/30°; spatial resolution, 1.4  1.4  1.6 mm3) during
pulmonary arterial contrast passage of a second gadolinium-
diethylenetriaminepentaacetic acid bolus (0.1 mmol/kg body-
weight; injection rate, 3.0 ml/s). All patients received supplemental
oxygen via a nasal cannula (2 to 6 l/min).
RV volumes were determined following Simpson’s rule. Pulmo-
nary CMR perfusion was evaluated visually for the presence of
lobar/segmental areas of relative hypoenhancement. Quantitative
pulmonary CMR perfusion parameters were derived from the
signal-intensity time curves in each of the 5 pulmonary lobes and
in the peripheral 2-cm border area of both lungs: relative peak
enhancement (%), maximum peak enhancement (%), wash-in rate(arbitrary unit), area under the curve (AUC), and time to peak
enhancement (seconds). To detect PE on 3-dimensional MR
angiography, the identical criteria used for MDCT were applied.
Group comparisons of continuous variables were performed
using the Student t test or Kruskal-Wallis test, as appropriate.
Categorical data were compared using the Fisher exact test.
Receiver-operating characteristic analysis was done to determine
the accuracy of pulmonary CMR perfusion testing. All statistical
analyses were performed with SPSS version 16.0 (SPSS Inc.,
Chicago, Illinois).
PE patients demonstrated significantly reduced systolic RV
ejection fraction compared with controls (47.1 10.4% vs. 57.2
2.9%, p  0.002). The diagnosis of PE was equally accurate on a
per-patient basis with both MDCT and MR angiography. In all
PE patients (12/12, 100%), pulmonary CMR perfusion imaging
clearly delineated lobar, segmental, or peripheral wedge-shaped
areas of relative hypoperfusion (normal pulmonary perfusion:
Fig. 1A, Online Video 1; pathological pulmonary perfusion:
Figs. 1B and 1C, Online Video 2). Hence, in PE patients, the
sensitivity of pulmonary CMR perfusion imaging, on a per-
patient, per-lung, and per-lobe basis, was 100%, 90.0%, 71.1%,
respectively, with corresponding kappa values of 1.0, 0.80, and
0.69. Comparing CMR perfusion of pulmonary lobes being
affected by PE with normal lobe relative peak enhancement (172
157% vs. 542  213%, p  0.001), maximum peak enhancement
314  198% vs. 691  264%, p  0.001), wash-in rate (89  72
vs. 184  77, p  0.001), and AUC (3,212  2,269 vs. 7,215 
3,199, p  0.001) were significantly reduced and time to peak
enhancement was significantly prolonged (median [interquartile
range]: 17.1 s [12.0 to 23.6 s] vs. 8.8 s [8.0 to 10.1 s], p  0.001).
Using the peripheral lung measurements, receiver-operating
characteristic analysis was done to determine the perfusion param-
eter with the highest diagnostic value for the detection of PE: the
AUC for maximum peak enhancement (0.88, 95% confidence
interval [CI]: 0.79 to 0.98) was best, but relative peak enhance-
ment (0.88, 95% CI: 0.77 to 0.99), wash-in rate (0.86, 95% CI:
0.75 to 0.97), AUC (0.83, 95% CI: 0.72 to 0.94), and time to peak
enhancement (0.78, 95% CI: 0.63 to 0.93) demonstrated good
discriminatory power as well.
Reportedly, CMR was considered highly sensitive for the
diagnosis of central PE, but showed reduced sensitivity for the
detection of segmental and especially subsegmental emboli.
In the current study, contrast-enhanced high-resolution CMR
pulmonary perfusion used the signal enhancement resulting from
pulmonary arterial blood supply with decreased or absent signal
indicating pulmonary arterial obstructive disease. Hence, CMR
pulmonary perfusion imaging primarily visualized the conse-
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signal enhancement, PE could be diagnosed as lobar, segmental, or
subsegmental with sharply delineated perfusion defects.
During a single-session examination, multicomponent CMR
delivered all functional and morphological information (i.e., pul-
monary arterial supply, RV function, and pulmonary perfusion)
directly and essentially related to adequate and rapid clinical
decision making. Such data may serve as a profound basis for
determination of therapeutic options in patients suspected of
having a PE.
The present study has some limitations. Because of limited
access to the patient in the magnetic resonance scanner environ-
ment and related safety concerns, hemodynamically unstable (i.e.,
severely hypotensive) patients were not examined. Total CMR
imaging time was 20 min with an additional 10 min for
evaluation/interpretation of image data. Hence, although the
duration of image data acquisition was prolonged compared with
Figure 1 High-Resolution Dynamic CMR Pulmonary Perfusion Imaging
High-resolution, k-t accelerated dynamic cardiac magnetic resonance (CMR) pu
diethylenetriaminepentaacetic acid bolus. (A) Normal pulmonary perfusion with h
clear differentiation of pulmonary arterial vessels and lung parenchyma. (B) Patho
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reformatted (MPR) images of pulmonary multidetector computed tomography angio
coronal MPR view demonstrating right-sided pulmonary emboli; II  axial slice imaMDCT, the multicomponent CMR imaging approach accuratelydelivered RV functional parameters (i.e., volumes together with
regional and global [dys]function) considered essential for further
therapeutic decision making.
In conclusion, taking full advantage of the radiation-free and
noninvasive multicomponent CMR approach, serial imaging could
potentially be used to assess and compare the efficiency of medical
measures designed to improve pulmonary perfusion and/or RV
function.
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Contemporary Patterns of Fractional Flow Reserve and Intravascular
Ultrasound Use Among Patients Undergoing Percutaneous Coronary
Intervention in the United Statesta RegistryTo the Editor: The use of fractional flow reserve (FFR) and
intravascular ultrasound (IVUS) to assess intermediate coronary
stenoses (defined as 40% to 70% stenosis) has been associated with
improved procedural and clinical outcomes (1,2) in patients un-
dergoing percutaneous coronary intervention (PCI). Both technol-
ogies received a Class IIa recommendation for use in angiographi-
cally intermediate coronary stenoses in the recently published 2011
American College of Cardiology/American Hospital Association
PCI guidelines (3). We undertook an analysis of the CathPCI
Registry data in order to better understand current patterns of use
of both FFR and IVUS associated with PCI of intermediate
lesions, and how their use might relate to procedural and patient-
based outcomes.
The CathPCI Registry is an initiative of the American College
of Cardiology Foundation and the Society for Cardiovascular
Angiography and Interventions and has been previously described
(4). We analyzed data for patients undergoing PCI of intermediate
coronary stenoses (defined as a percent diameter stenosis 40%
and 70%). Patients were excluded if PCI was performed for a
nonintermediate stenosis (n  373,320), if they underwent diag-
nostic angiography only (n  1,977), or if they underwent both
FFR and IVUS (n  778). We examined data starting from April
2009 when version 4 of the CathPCI Registry data collection form
began to be implemented, as IVUS and FFR use for PCI of
intermediate stenoses were not collected in earlier versions.
Descriptive statistics on the study population were grouped by
lesion assessment (angiography only [AO], FFR, or IVUS).
Categorical variables were presented as percentages, and continu-
ous variables were presented as medians along with the interquar-
tile range (IQR). Comparisons between groups were performed
using Pearson chi-square tests for categorical variables and the
Kruskal-Wallis test or Wilcoxon test for continuous variables.
Logistic regression with generalized estimating equations to ac-hospital mortality and procedural success adjusting for baseline
patient characteristics in the CathPCI Registry mortality risk
model. All analyses were performed using SAS version 9.2 (SAS
Institute, Cary, North Carolina).
Data for 61,874 attempted coronary interventions of interme-
diate coronary stenoses performed between April 2009 and Sep-
tember 2010 were available for analysis. Among these, FFR was
used in 3,763 (6.1%) patients, IVUS was used in 12,589 (20.3%)
patients, and 45,522 (73.6%) patients had lesions assessed by AO
(Table 1). Compared with patients who underwent AO, patients
undergoing FFR were more likely to be younger (p  0.0001) and
more frequently male (p  0.0001), with slightly lower rates of
diabetes (p  0.017) and hypertension (p  0.0003), and higher
rates of dyslipidemia (p  0.0001). Patients undergoing IVUS
were younger (p  0.0001) and less frequently male (p  0.0001),
with slightly lower rates of diabetes (p  0.0001) and similar rates
of hypertension (p  0.75) and dyslipidemia (p  0.31).
Patients undergoing FFR were more likely to have had their
procedure performed in a university hospital (p  0.0001) com-
pared with private and community hospitals (p  0.0001) and in a
hospital with a fellowship or residency training program (p 0.0001).
Patients who underwent FFR were less likely to present with an
acute coronary syndrome (ST-segment elevation myocardial in-
farction, non–ST-segment elevation myocardial infarction, and
unstable angina; p  0.0001). Patients who underwent IVUS
were more likely to undergo stress testing prior to the procedure
(p  0.0001). Patients undergoing FFR were more likely to
have had a prior stress test that had negative or equivocal
findings (p  0.0001).
Patients undergoing FFR and/or IVUS were less likely to have
multivessel disease (p  0.0001), and more likely to have a lesion
deemed high risk (p  0.0001). Both the FFR and IVUS cohorts
had longer fluoroscopy times (p  0.0001) and more contrast use
(p  0.0001) as compared with the AO group.
